Oral versus intravenous fluoropyrimidines for metastatic colorectal cancer

Andrew Strickland, Peter Harper, Christos Karapetis, Christopher B. Steer, Desmond Yip

Research output: Contribution to journalReview articlepeer-review

25 Downloads (Pure)


This is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to conduct a systematic review of the randomised trials comparing intravenous 5-fluorouracil with any oral fluoropyrimidine to assess the effect of chemotherapy on overall survival in patients with colo-rectal cancer. Our secondary objective will be to assess the relative response rates, toxicities and effects on quality of life of these two treatments.

Original languageEnglish
Article numberCD002889
JournalCochrane Database of Systematic Reviews
Issue number5
Publication statusPublished - 20 May 2016
Externally publishedYes


Dive into the research topics of 'Oral versus intravenous fluoropyrimidines for metastatic colorectal cancer'. Together they form a unique fingerprint.

Cite this